Register for real-time alerts, custom portfolio, and market movers

Get Started

NBSE NeuBase Therapeutics Inc

0.378

0.00 (0.00%)

Last Updated: 20:00:00

Delayed by 15 minutes

NeuBase Therapeutics names Phathom's Todd Branning as new CFO

To read the full story on Seeking Alpha, click here.

NeuBase Therapeutics (NASDAQ:NBSE)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more NeuBase Therapeutics Charts.

NeuBase Therapeutics (NASDAQ:NBSE)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more NeuBase Therapeutics Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

NeuBase Therapeutics Inc News

More NeuBase Therapeutics Inc News Articles

TransCode Therapeutics

Impact Fusion (PK)

Brookmount Explorations (PK)

Branded Legacy (PK)

NaturalShrimp (QB)

Valiant Eagle (PK)

Enzolytics (PK)

CyberFuels (PK)

1812 Brewing (PK)

Hannover House (PK)

ERHC Energy (CE)

RespireRx Pharmaceuticals (CE)

Delayed Upgrade Clock